Skip to Content

The Value of DEX Z-Codes®: Empowering Payers with Genetic Test Identification & Quality Insights

Aug 22, 2023
12:00 pm EDT
Presented by Optum – An AHIP Select Member
Register Now Registration takes place at a third-party website.

About This Webinar

The genetic test industry continues to grow at a rapid rate with 10+ new genetic tests hitting the market each day. At the same time, the number of CPT codes identifying these tests is not at a 1:1 ratio, and the number of individuals qualified to interpret the quality of these tests is limited. This lack of genetic test specificity coupled with the variability in the quality and utility of precision medicine tests, creates challenges for health plans throughout the adjudication process.

Join Optum and Palmetto experts as they walk through a clinical scenario highlighting the complexities of genetic testing management and learn how DEX Z-Codes® empower health plans with discrete test identification and quality insights to drive transparency throughout the claims process.

In this session, attendees will learn how they can better manage genetic testing lab benefits and drive quality tests by adopting DEX Z-Codes®.

Attendees Will Learn About

  • The challenges health insurance providers face when genetic tests are not identified at the discreet test level
  • How DEX Z-Codes® are not just an “administrative identifier,” and how they are a commitment to establishing base test quality through a multifaceted and expert driven process
  • How the adoption of DEX Z-Codes® enables quality and price transparency throughout the adjudication process creating less administrative burden


Cristi Radford, MS, CGC

Product Director


Cristi Radford, MS, CGC, Product Director, is part of the team developing and launching genetic test management capabilities within Optum’s laboratory benefit management solution. Previously, Ms. Radford served as Director of Genetics, Clinical Initiatives for UnitedHealthcare, where she was responsible for developing and implementing strategies to improve access to genetic testing and…

Learn more about Cristi Radford, MS, CGC

Megan Landsverk, PhD

Director, Molecular Diagnostics Program

Palmetto GBA, LLC

Dr. Landsverk is a Director in the Molecular Diagnostics program at Palmetto GBA. Dr. Landsverk received her PhD in Biochemistry & Molecular Biology from Baylor College of Medicine, and postdoctoral training in Medical Genetics at the University of Washington. She is a board-certified Molecular Geneticist, completing her molecular genetics fellowship training at Baylor College of Medicine.…

Learn more about Megan Landsverk, PhD